| VANDA PHARMACEUTICALS |
| USA |
| Gesundheit |
| US9216591084 / A0JJT3 |
| VM4 (Frankfurt) / VNDA (NASDAQ) |
| FRA:VM4, ETR:VM4, VM4:GR, NASDAQ:VNDA |
| - |
| https://www.vandapharma.c.. |
|
Vanda Pharmaceuticals Inc. is a global biopharmaceutical company focused on developing and commercializing therapies for high unmet medical needs. Its current portfolio centers on treatments for sleep-wake disorders, schizophrenia, and other central ..
>Volltext.. |
| 216.43 Mio. EUR |
| 87.29 Mio. EUR |
| 192.57 Mio. EUR |
| -152.22 Mio. EUR |
| -245.35 Mio. EUR |
| -4.13 EUR |
| 20.38 Mio. EUR |
| 49.98 Mio. EUR |
| -127.06 Mio. EUR |
| 1.04 |
| 9.36% |
| -323.53% |
| - |
| - |
| - |
| - |
| VANDA |
| 27.10.26 |